HFrEF and The Obstacles of Initiation to Optimization of GDMT
APSC Emerging Leaders Teaching Moments in Heart Failure Series 2 Date: 5th October 2023, Thursday Time: 1800-1915 (SG Time) / UTC +8 Topic: HFrEF and The Obstacles of Initiation to Optimization of GDMT Chairpersons Gary Gan Consultant Cardiologist and Clinical Lead of Heart Failure Services Westmead and Blacktown Hospital Sydney, New South Wales, Australia Vebiona Kartini Prima Putri Cardiologist Heart Failure Clinic Awal Bros Hospital, Pekanbaru Indonesia Speakers Lecture title: GDMT from Initiation to Optimization and New Spectrum of Therapies Randy Koh Cardiologist National Heart Institute, Malaysia Case discussion 1: Leonardo Paskah Suciadi Cardiologist, Siloam Hospital Kebon Jeruk Indonesia Case discussion 2: Kay Evangelista Heart Failure Specialist Philippine General Hospital, Manila Philippines Panellist Andrew Sindone Director Heart Failure Unit and Department of Cardiac Rehabilitation Concord Hospital and Head of Department of Cardiology, Ryde Hospital Australia Julian Kenrick Loh Consultant National Heart Centre Singapore Singapore Enclosed by Singapore Cardiac Society

Approach and Management of Acute Heart Failure

GDMT in Heart Failure – The Power of Pills: Opportunities and Challenges (Michelle Kittleson, MD)

2024 HFMC: Managing Worsening Heart Failure with Reduced Ejection Fraction

Understanding VO2 Max: Why Exercise Matters for Heart Health and Longevity

Food is medicine - closing the gap on malnutrition with a new ISO standard for hospitals

Heart failure GDMT Titration - Focus on Beta-Blockers, ARNI, and Ivabradine | Cardiovascular 2023

APSC-EECC Core Cardiology Review Series Season 2 - Rhythm Disorders in a Nutshell

Implementing Quadruple Medical Therapy for Heart Failure with Reduced Ejection Fraction

APSC - EECC Core Cardiology Review Series - Heart Failure, Cardiomyopathy & Pericardial Diseases

High CAC Score: What It Means and Exactly What to Do Next

Rapid And Intensive GDMT For Heart Failure

Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC) webinar

Updates in Treatment Pathways for Patients with Heart Failure

New Heart Failure Guidelines: Impact on the Patient Journey, a Healthcare Professional Perspective

Dr. McMurray discusses the DAPA-HF trial of dapagliflozin in systolic heart failure

9/23/2022: The Medical Therapy of Heart Failure in 2022

The AI Blueprint: How To Use AI To Make Millions, & Change Your Life w/ Alicia Lyttle 🚀

APSC-EECC Core Cardiology Review Series: Mending A Broken Heart – Managing Heart Failure

Finerenone in Patients With Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | HFSA 2024

